Phibro Animal Health (PAHC) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | $44.00 from $62.00 | May 14, 2026 |
| Citigroup | Initiated Coverage | Neutral | $62.00 | Apr 15, 2026 |
| JP Morgan | Maintained | Overweight | $50.00 from $45.00 | Nov 7, 2025 |
| B of A Securities | Maintained | Underperform | $27.00 from $19.00 | Aug 29, 2025 |
| JP Morgan | Upgraded | Neutral → Overweight | $35.00 from $25.00 | Jul 7, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $26.00 from $21.00 | Jun 25, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $21.00 from $20.00 | May 8, 2025 |
| Barclays | Maintained | Underweight | $22.00 from $20.00 | Feb 10, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $25.00 from $20.00 | Dec 17, 2024 |
| Barclays | Maintained | Underweight | $20.00 from $13.00 | Nov 12, 2024 |
| JP Morgan | Initiated Coverage | Neutral | $22.00 | Sep 10, 2024 |
| B of A Securities | Maintained | Underperform | $15.00 from $13.00 | Aug 30, 2024 |
| Barclays | Maintained | Underweight | $13.00 from $10.00 | May 10, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $16.00 from $17.00 | Nov 9, 2023 |
| Roth MKM | Maintained | Buy | $21.00 | Sep 1, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $17.00 from $18.00 | Aug 31, 2023 |
| Roth MKM | Maintained | Buy | $21.00 | Aug 29, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $18.00 | Jul 27, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $18.00 from $19.00 | May 4, 2023 |
Frequently asked questions
Is PAHC a buy, sell, or hold?
Analysts covering Phibro Animal Health currently average a Hold rating: 1 buy, 3 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PAHC?
On May 14, 2026, Citigroup maintained Phibro Animal Health at Neutral with a price target of $44.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.